| AB FCP II-EMERGING MARKETS VALUE PORTFOLIO A EUR | RVI EMERGENTES VALOR | 57,57% | 86,93% | 70,39% | 154,41% |
| UBS MSCI EM INDEX FUND USD I-A ACC | RVI EMERGENTES | 45,45% | · | 44,66% | 154,41% |
| NORDEA 1-EMERGING SUSTAINABLE STARS EQUITY FUND BP-EUR | RVI EMERGENTES | 52,93% | 74,10% | 20,01% | 154,39% |
| ISHARES MSCI EM UCITS ETF USD (ACC) | RVI EMERGENTES | 45,37% | 77,07% | 46,58% | 154,35% |
| PICTET - BIOTECH R USD | RVI BIOTECNOLOGÍA | 83,03% | 78,06% | 54,27% | 154,26% |
| MFS MERIDIAN GLOBAL EQUITY INCOME FUND I1-USD | RVI GLOBAL VALOR | 24,85% | 46,55% | 64,35% | 154,22% |
| GOLDMAN SACHS MULTI-MANAGER EMERGING MARKETS EQUITY PORTFOLIO I CAP USD | RVI EMERGENTES | 50,15% | 85,07% | 48,38% | 154,20% |
| JPM EUROPE STRATEGIC GROWTH A (ACC) EUR | RVI EUROPA CRECIMIENTO | 18,88% | 45,63% | 40,98% | 154,11% |
| PARTNERS GROUP LISTED INVESTMENTS SICAV - LISTED PRIVATE EQUITY USD P ACC | RVI GLOBAL | -13,56% | 26,55% | 15,34% | 154,11% |
| FIDELITY FUNDS-ASIA EQUITY ESG A-ACC-EUR | RVI ASIA EX-JAPÓN | 48,51% | 54,46% | 25,43% | 154,10% |
